Skip to content

Early use of donepezil against psychosis and cognitive decline in Parkinson's disease: a randomised controlled trial for 2 years.

Randomized controlled trial · J Neurol Neurosurg Psychiatry · 2018. Source record refreshed; an explanation has not been reviewed.

Randomized controlled trialSource: PubMed · PMID 30076270

About this paper

This page identifies the publication and its source. A checked explanation of its findings is not yet available.

Reading this record

Checking bibliographic metadata does not verify a study’s conclusions or any advice previously linked to it.

CHECK THE ORIGINAL

Publication details

Early use of donepezil against psychosis and cognitive decline in Parkinson's disease: a randomised controlled trial for 2 years.

Sawada H, Oeda T, Kohsaka M et al.
J Neurol Neurosurg Psychiatry · 2018

PubMed ID
30076270
Record checked

A checked publication record confirms source details. It does not verify a health claim or assess the quality of the study. Our approach.